Genetic variation in TP53 and risk of breast cancer in a population-based case-control study

Carcinogenesis

Volumn 28, Issue 8, 2007, Pages 1680-1686

  Sprague, Brian L ^a,b   Trentham Dietz, Amy ^a,b   Garcia Closas, Montserrat ^c   Newcomb, Polly A ^b,d   Titus Ernstoff, Linda ^e   Hampton, John M ^b   Chanock, Stephen J ^c   Haines, Jonathan L ^f   Egan, Kathleen M ^g  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e NORRIS COTTON CANCER CENTER   (United States)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^g H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INVASION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; UNITED STATES;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; MENOPAUSE; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; VARIATION (GENETICS);

EID: 34548094807     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm097     Document Type: Article

References (30)

1. Vogelstein,B. et al. (2000) Surfing the p53 network. Nature, 408, 307-310.
2. Prives,C. et al. (1999) The p53 pathway. J. Pathol., 187 112-126.
3. Vogelstein,B. et al. (2004) Cancer genes and the pathways they control. Nat. Med., 10, 789-799.
4. Olivier,M. et al. (2002) The IARC TP53 database: New online mutation analysis and recommendations to users. Hum. Mutat., 19 607-614.
5. Hamroun,D. et al. (2006) The UMD TP53 database and website: Update and revisions. Hum. Mutat., 27, 14-20.
6. Borresen-Dale,A.L. (2003) TP53 and breast cancer. Hum. Mutat., 21, 292-300.
7. Srivastava,S. et al. (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348, 747-749.
8. Malkin,D. et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233-1238.
9. Varley,J.M. (2003) Germline TP53 mutations and Li-Fraumeni syndrome. Hum. Mutat., 21, 313-320.
10. Garber,J.E. et al. (1991) Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res., 51, 6094-6097.
11. Packer,B.R. et al. (2006) SNP500Cancer: A public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res., 34 D617-D621.
12. The Breast Cancer Association Consortium. (2006) Commonly studied single-nucleotide polymorphisms and breast cancer results from the breast cancer association consortium. J. Natl Cancer Inst., 98 1382-1396.
13. Mavridou,D. et al. (1998) TP53 intron 6 polymorphism and the risk of ovarian and breast cancer. Br. J. Cancer, 77, 676-677.
14. Sjalander,A. et al. (1996) p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis, 17, 1313-1316.
15. Weston,A. et al. (1997) p53 haplotype determination in breast cancer. Cancer Epidemiol. Biomarkers Prev., 6, 105-112.
16. Wang-Gohrke,S. et al. (1998) p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res., 18, 2095-2099.
17. Wang-Gohrke,S. et al. (2002) Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years. Pharmacogenetics, 12, 269-272.
18. Peller,S. et al. (1995) A novel polymorphism in intron 6 of the human p53 gene: A possible association with cancer predisposition and susceptibility. DNA Cell Biol., 14, 983-990.
19. Khaliq,S. et al. (2000) P53 mutations, polymorphisms, and haplotypes in Pakistani ethnic groups and breast cancer patients. Genet. Test., 4, 23-29.
20. Weston,A. et al. (1998) True extended haplotypes of p53: indicators of breast cancer risk. Cancer Genet. Cytogenet., 102 153-154.
21. Keshava,C. et al. (2002) Waf-1 (p21) and p53 polymorphisms in breast cancer. Cancer Epidemiol. Biomarkers Prev., 11, 127-130.
22. Garcia-Closas,M. et al. (2006) Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: Two population-based studies in USA and Poland, and meta-analyses. Hum. Genet., 119 376-388.
23. Garcia-Closas,M. et al. (2001) Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol. Biomarkers Prev., 10, 687-696.
24. Liang,X. et al. Whole genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancer. Cancer Epidemiol Biomarkers Prev. (In Press).
25. Stephens,M. et al. (2001) A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet., 68, 978-989.
26. Stephens,M. et al. (2005) Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am. J. Hum. Genet., 76, 449-462.
27. Garcia-Closas,M. et al. Common genetic variation in TP53 and its flanking genes, WDR79 and susceptibility to breast cancer. Int. J. Cancer (In Press).
28. Malkinson,A.M. et al. (1994) The intronic structure of cancer-related genes regulates susceptibility to cancer. Mol. Carcinog., 10, 61-65.
29. Tabor,H.K. et al. (2002) Opinion: Candidate-gene approaches for studying complex genetic traits: Practical considerations. Nat. Rev. Genet., 3, 391-397.
30. Lukas,J. et al. (2000) p53 mutations and expression in breast carcinoma in situ. Am. J. Pathol., 156, 183-191.